Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)

被引:3
作者
Bourgonje, Arno R. [1 ,2 ]
Connelly, Margery A. [3 ]
van Goor, Harry [4 ]
van Dijk, Peter R. [5 ]
Dullaart, Robin P. F. [5 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, POB 30-001, NL-9700 RB Groningen, Netherlands
[2] Icahn Sch Med Mt Sinai, Dept Med, Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[3] Labcorp, Morrisville, NC USA
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Endocrinol, Groningen, Netherlands
关键词
Type; 2; diabetes; Microvascular complications; Lipoproteins; HDL; LDL; DENSITY-LIPOPROTEIN CHOLESTEROL; INCREASED LARGE VLDL; INSULIN-RESISTANCE; MELLITUS; DISEASE; LIPIDS; SUSCEPTIBILITY; DYSLIPIDEMIA; PREVALENCE; SIZE;
D O I
10.1186/s12933-023-01909-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundTriglyceride-rich lipoproteins (TRL) and low-density lipoproteins (LDL) are associated positively whereas high-density lipoproteins (HDL) are associated inversely with the development of new-onset type 2 diabetes (T2D). Here we studied potential associations between these lipoprotein particle concentrations and the risk of developing microvascular complications in patients with established T2D.MethodsLipoprotein particle concentrations (TRLP, LDLP, and HDLP) were determined in 278 patients with T2D participating in a primary care-based longitudinal cohort study (Zwolle Outpatient Diabetes project Integrating Available Care [ZODIAC] study) leveraging the Vantera nuclear magnetic resonance (NMR) platform using the LP4 algorithm. Associations between lipoprotein particles and incident microvascular complications (nephropathy, neuropathy, and retinopathy) were assessed using Cox proportional hazards regression models.ResultsIn total, 136 patients had microvascular complications at baseline. During a median follow-up of 3.2 years, 49 (34.5%) of 142 patients without microvascular complications at baseline developed new-onset microvascular complications. In multivariable Cox proportional hazards regression analyses, both total LDLP and HDLP concentrations, but not total TRLP concentrations, were positively associated with an increased risk of developing any microvascular complications after adjustment for potential confounding factors, including age, sex, disease duration, HbA1c levels, history of macrovascular complications, and statin use (adjusted hazard ratio [HR] per 1 SD increment: 1.70 [95% CI 1.24-2.34], P < 0.001 and 1.63 [95% CI 1.19-2.23], P = 0.002, respectively). When analyzing each microvascular complication individually, total LDLP concentrations were positively associated with retinopathy (adjusted HR 3.35, 95% CI 1.35-8.30, P = 0.009) and nephropathy (adjusted HR 2.13, 95% CI 1.27-3.35, P = 0.004), and total HDLP concentrations with neuropathy (adjusted HR 1.77, 95% CI 1.15-2.70, P = 0.009). No significant associations were observed for lipoprotein particle subfractions.ConclusionsTotal lipoprotein particle concentrations of both LDL and HDL associate positively with an increased risk of developing microvascular complications in T2D. We propose that the protective role of HDL on the development of microvascular complications may be lost in established T2D.
引用
收藏
页数:11
相关论文
共 57 条
  • [1] Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62)
    Bourgonje, Arno R.
    van der Vaart, Amarens
    Gruppen, Eke G.
    van Goor, Harry
    Bakker, Stephan J. L.
    Connelly, Margery A.
    van Dijk, Peter R.
    Dullaart, Robin P. F.
    [J]. ENDOCRINE, 2023, 80 (02) : 312 - 316
  • [2] SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B
    CHAIT, A
    BRAZG, RL
    TRIBBLE, DL
    KRAUSS, RM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) : 350 - 356
  • [3] Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
    Chehade, Joe M.
    Gladysz, Margaret
    Mooradian, Arshag D.
    [J]. DRUGS, 2013, 73 (04) : 327 - 339
  • [4] Utility of apolipoprotein measurements in predicting incident type 2 diabetes: A Chinese cohort study
    Chou, Yu-Ching
    You, San-Lin
    Bai, Chyi-Huey
    Liao, Yu-Chan
    Wei, Cheng-Yu
    Sun, Chien-An
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 51 - 58
  • [5] Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
    Corsetti, James P.
    Sparks, Charles E.
    James, Richard W.
    Bakker, Stephan J. L.
    Dullaart, Robin P. E.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [6] Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk
    Corsetti, James P.
    Bakker, Stephan J. L.
    Gansevoort, Ronald T.
    Gruppen, Eke G.
    Connelly, Margery A.
    Sparks, Charles E.
    Dullaart, Robin P. F.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04):
  • [7] Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants
    Corsetti, James P.
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    Sparks, Charles E.
    Vart, Priya
    Dullaart, Robin P. F.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (12): : 2906 - 2915
  • [8] Inflammation reduces HDL protection against primary cardiac risk
    Corsetti, James P.
    Gansevoort, Ron T.
    Sparks, Charles E.
    Dullaart, Robin P. F.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (06) : 483 - 489
  • [9] High-density lipoprotein cholesterol in diabetes: Is higher always better?
    Costacou, Tina
    Evans, Rhobert W.
    Orchard, Trevor J.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (05) : 387 - 394
  • [10] Derangements of Intravascular Remodeling of Lipoproteins in Type 2 Diabetes Mellitus: Consequences for Atherosclerosis Development
    Dallinga-Thie, Geesje M.
    Dullaart, Robin P. F.
    van Tol, Arie
    [J]. CURRENT DIABETES REPORTS, 2008, 8 (01) : 65 - 70